$79.7 Million is the total value of Virtus ETF Advisers LLC's 244 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 55.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VPU | Sell | VANGUARD WORLD FDSutilities etf | $2,690,000 | -21.3% | 23,070 | -21.2% | 3.38% | +632.3% |
| EXEL | Sell | EXELIXIS INC | $1,110,000 | -12.9% | 36,522 | -30.6% | 1.39% | +709.9% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $1,059,000 | -26.6% | 13,652 | -42.0% | 1.33% | +581.5% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $1,050,000 | +12.7% | 7,098 | -10.7% | 1.32% | +946.0% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $1,031,000 | -22.9% | 67,813 | -9.3% | 1.29% | +618.9% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $1,029,000 | -31.8% | 17,531 | -45.6% | 1.29% | +536.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $1,022,000 | -19.0% | 6,818 | -17.9% | 1.28% | +654.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $1,015,000 | -24.6% | 14,929 | -8.7% | 1.27% | +600.0% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $1,009,000 | -25.1% | 16,891 | -69.9% | 1.27% | +595.6% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $996,000 | -29.7% | 17,897 | -42.7% | 1.25% | +554.5% |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $991,000 | -30.2% | 46,214 | -23.0% | 1.24% | +551.3% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $981,000 | -27.9% | 48,401 | -38.2% | 1.23% | +572.7% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $981,000 | -19.5% | 7,161 | -20.0% | 1.23% | +650.6% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $973,000 | -7.2% | 10,910 | -3.1% | 1.22% | +766.0% |
| BIIB | Sell | BIOGEN INC | $953,000 | -25.5% | 2,990 | -26.8% | 1.20% | +595.3% |
| GILD | Sell | GILEAD SCIENCES INC | $952,000 | -26.2% | 13,288 | -16.6% | 1.20% | +586.8% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $936,000 | -9.4% | 18,610 | -8.7% | 1.18% | +745.3% |
| RTRX | Sell | RETROPHIN INC | $933,000 | -33.8% | 44,297 | -21.8% | 1.17% | +516.3% |
| RXDX | Sell | IGNYTA INC | $612,000 | +29.1% | 22,936 | -40.2% | 0.77% | +1100.0% |
| IMMU | Sell | IMMUNOMEDICS INC | $456,000 | -23.7% | 28,196 | -34.1% | 0.57% | +606.2% |
| XLRN | Sell | ACCELERON PHARMA INC | $414,000 | +1.0% | 9,748 | -11.2% | 0.52% | +845.5% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $411,000 | -21.0% | 32,118 | -24.0% | 0.52% | +637.1% |
| RGNX | Sell | REGENXBIO INC | $407,000 | -28.5% | 12,251 | -29.1% | 0.51% | +563.6% |
| FGEN | Sell | FIBROGEN INC | $405,000 | -33.3% | 8,541 | -24.3% | 0.51% | +519.5% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $399,000 | -14.0% | 6,057 | -34.5% | 0.50% | +695.2% |
| MYOK | Sell | MYOKARDIA INC | $398,000 | -16.7% | 9,447 | -15.4% | 0.50% | +679.7% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $392,000 | -31.9% | 27,241 | -28.7% | 0.49% | +530.8% |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $391,000 | -11.9% | 10,336 | -42.3% | 0.49% | +718.3% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $383,000 | +19.3% | 98,726 | -21.9% | 0.48% | +1018.6% |
| AVXS | Sell | AVEXIS INC | $383,000 | -14.5% | 3,464 | -25.3% | 0.48% | +701.7% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $370,000 | +0.5% | 9,390 | -20.7% | 0.46% | +828.0% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $365,000 | -56.5% | 3,733 | -54.0% | 0.46% | +305.3% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $360,000 | +36.4% | 2,187 | -48.3% | 0.45% | +1155.6% |
| JUNO | Sell | JUNO THERAPEUTICS INC | $359,000 | -43.9% | 7,860 | -44.9% | 0.45% | +423.3% |
| INSM | Sell | INSMED INC | $358,000 | -44.8% | 11,494 | -44.7% | 0.45% | +416.1% |
| SGMO | Sell | SANGAMO BIOSCIENCES INC | $354,000 | -46.4% | 21,591 | -50.9% | 0.44% | +398.9% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $353,000 | -31.9% | 2,775 | -37.1% | 0.44% | +532.9% |
| GLYC | Sell | GLYCOMIMETICS INC | $352,000 | -13.1% | 20,957 | -27.6% | 0.44% | +703.6% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $348,000 | -41.2% | 4,611 | -45.7% | 0.44% | +446.2% |
| IMGN | Sell | IMMUNOGEN INC | $346,000 | -35.4% | 53,977 | -22.9% | 0.43% | +502.8% |
| BLUE | Sell | BLUEBIRD BIO INC | $345,000 | -14.6% | 1,939 | -34.2% | 0.43% | +701.9% |
| MGNX | Sell | MACROGENICS INC | $343,000 | +0.6% | 18,057 | -2.1% | 0.43% | +834.8% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $339,000 | -22.4% | 16,059 | -33.3% | 0.42% | +620.3% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $338,000 | -15.5% | 118,969 | -14.9% | 0.42% | +685.2% |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $337,000 | -15.8% | 47,426 | -15.2% | 0.42% | +683.3% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $335,000 | -30.6% | 23,102 | -24.5% | 0.42% | +546.2% |
| NVAX | Sell | NOVAVAX INC | $329,000 | -6.3% | 265,206 | -14.0% | 0.41% | +778.7% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $322,000 | -23.9% | 40,259 | -26.2% | 0.40% | +608.8% |
| Exit | PLAINS ALL AMERN PIPELINE Lcall | $0 | – | -450 | -100.0% | 0.00% | – | |
| Exit | MARATHON PETE CORPcall | $0 | – | -2,885 | -100.0% | 0.00% | – | |
| Exit | ENERGY TRANSFER PARTNERS LPcall | $0 | – | -100 | -100.0% | 0.00% | – | |
| Exit | ONEOK INC NEWcall | $0 | – | -201 | -100.0% | 0.00% | – | |
| Exit | ENTERPRISE PRODS PARTNERS Lcall | $0 | – | -300 | -100.0% | 0.00% | – | |
| Exit | WILLIAMS COS INC DELput | $0 | – | -800 | -100.0% | -0.00% | – | |
| Exit | UNITED STATES NATL GAS FUNDput | $0 | – | -744 | -100.0% | -0.00% | – | |
| Exit | ISHARES TRput | $0 | – | -1,400 | -100.0% | -0.00% | – | |
| Exit | MARATHON PETE CORPput | $0 | – | -1,607 | -100.0% | -0.00% | – | |
| Exit | KINDER MORGAN INC DELcall | $0 | – | -4,000 | -100.0% | -0.00% | – | |
| Exit | ISHARES TRcall | $0 | – | -12,432 | -100.0% | -0.00% | – | |
| Exit | ONEOK INC NEWput | $0 | – | -2,000 | -100.0% | -0.00% | – | |
| Exit | ENERGY TRANSFER EQUITY L Pput | $0 | – | -7,942 | -100.0% | -0.00% | – | |
| Exit | JPMORGAN CHASE & COcall | $0 | – | -9,000 | -100.0% | -0.01% | – | |
| VSAR | Exit | VERSARTIS INC | $0 | – | -19,991 | -100.0% | -0.01% | – |
| Exit | UNITED STATES NATL GAS FUNDcall | $0 | – | -41,012 | -100.0% | -0.01% | – | |
| DM | Exit | DOMINION MIDSTREAM PARTNERS | $0 | – | -3,189 | -100.0% | -0.01% | – |
| Exit | SPDR S&P 500 ETF TRcall | $0 | – | -1,800 | -100.0% | -0.02% | – | |
| Exit | UNITED STATES OIL FUND LPcall | $0 | – | -87,212 | -100.0% | -0.02% | – | |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -34,183 | -100.0% | -0.04% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -23,869 | -100.0% | -0.05% | – |
| SHLX | Exit | SHELL MIDSTREAM PARTNERS L Punit ltd int | $0 | – | -18,010 | -100.0% | -0.07% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -247,030 | -100.0% | -0.10% | – |
| GDX | Exit | VANECK VECTORS ETF TRgold miners etf | $0 | – | -37,167 | -100.0% | -0.12% | – |
| SEP | Exit | SPECTRA ENERGY PARTNERS LP | $0 | – | -22,367 | -100.0% | -0.13% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -148,929 | -100.0% | -0.15% | – |
| CQP | Exit | CHENIERE ENERGY PARTNERS LP | $0 | – | -43,552 | -100.0% | -0.17% | – |
| FNCL | Exit | FIDELITYmsci finls idx | $0 | – | -33,040 | -100.0% | -0.17% | – |
| ENB | Exit | ENBRIDGE INC | $0 | – | -34,816 | -100.0% | -0.20% | – |
| WELLPRI | Exit | WELLTOWER INC6.50% pfd prepet | $0 | – | -25,828 | -100.0% | -0.22% | – |
| TRGP | Exit | TARGA RES CORP | $0 | – | -90,638 | -100.0% | -0.58% | – |
| WGP | Exit | WESTERN GAS EQUITY PARTNERS | $0 | – | -139,927 | -100.0% | -0.78% | – |
| ENLC | Exit | ENLINK MIDSTREAM LLC | $0 | – | -364,345 | -100.0% | -0.85% | – |
| TCP | Exit | TC PIPELINES LP | $0 | – | -123,526 | -100.0% | -0.87% | – |
| NGL | Exit | NGL ENERGY PARTNERS LP | $0 | – | -617,529 | -100.0% | -0.96% | – |
| AM | Exit | ANTERO MIDSTREAM PARTNERS LPunt ltd partn | $0 | – | -254,406 | -100.0% | -1.08% | – |
| DCP | Exit | DCP MIDSTREAM PARTNERS LP | $0 | – | -233,301 | -100.0% | -1.09% | – |
| CEQP | Exit | CRESTWOOD EQUITY PARTNERS LPunit ltd partner | $0 | – | -334,558 | -100.0% | -1.10% | – |
| WMB | Exit | WILLIAMS COS INC DEL | $0 | – | -316,952 | -100.0% | -1.28% | – |
| TEP | Exit | TALLGRASS ENERGY PARTNERS LP | $0 | – | -204,111 | -100.0% | -1.32% | – |
| NS | Exit | NUSTAR ENERGY LP | $0 | – | -260,030 | -100.0% | -1.42% | – |
| KMI | Exit | KINDER MORGAN INC DEL | $0 | – | -565,747 | -100.0% | -1.46% | – |
| WES | Exit | WESTERN GAS PARTNERS LP | $0 | – | -246,660 | -100.0% | -1.70% | – |
| GEL | Exit | GENESIS ENERGY L Punit ltd partn | $0 | – | -529,074 | -100.0% | -1.88% | – |
| PSXP | Exit | PHILLIPS 66 PARTNERS LP | $0 | – | -284,541 | -100.0% | -2.02% | – |
| PAA | Exit | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $0 | – | -721,306 | -100.0% | -2.06% | – |
| OKE | Exit | ONEOK INC NEW | $0 | – | -300,355 | -100.0% | -2.24% | – |
| MMP | Exit | MAGELLAN MIDSTREAM PRTNRS LP | $0 | – | -246,189 | -100.0% | -2.36% | – |
| EQM | Exit | EQT MIDSTREAM PARTNERS LPunit ltd partn | $0 | – | -323,612 | -100.0% | -3.27% | – |
| ANDX | Exit | ANDEAVOR LOGISTICS LP | $0 | – | -557,073 | -100.0% | -3.76% | – |
| MPC | Exit | MARATHON PETE CORP | $0 | – | -508,655 | -100.0% | -3.84% | – |
| ENLK | Exit | ENLINK MIDSTREAM PARTNERS LP | $0 | – | -1,735,472 | -100.0% | -3.92% | – |
| EEP | Exit | ENBRIDGE ENERGY PARTNERS L P | $0 | – | -2,137,474 | -100.0% | -4.60% | – |
| MPLX | Exit | MPLX LP | $0 | – | -1,021,677 | -100.0% | -4.82% | – |
| EPD | Exit | ENTERPRISE PRODS PARTNERS L | $0 | – | -1,541,809 | -100.0% | -5.42% | – |
| ET | Exit | ENERGY TRANSFER EQUITY L P | $0 | – | -2,599,426 | -100.0% | -6.09% | – |
| BPL | Exit | BUCKEYE PARTNERS L Punit ltd partn | $0 | – | -857,445 | -100.0% | -6.59% | – |
| WPZ | Exit | WILLIAMS PARTNERS L P NEW | $0 | – | -1,671,737 | -100.0% | -8.77% | – |
| ETP | Exit | ENERGY TRANSFER PARTNERS LPunit ltd prt int | $0 | – | -5,114,749 | -100.0% | -12.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.